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The in vitro interaction between human a,-proteinase inhibitor @,-PI) and cholesterol was studied with electrophoretic and gel chromatographic 
methods. The addition of cholesterol (from 1 to 20 mol/mol a,-PI) at 37’C resulted in retarded electrophoretic mobility of a,-PI towards the anode, 
diminished immunoreactivity and antiproteinase activity. At a molar ratio of 2:l (cholesterol/a,-PI), antitryptic activity was reduced by 15% but 
antielastase- activity by 50%. At this ratio the gel filtration a,-PI peak appeared at 67 kDa, as compared to 52 kDa for native a,-PI. No size difference 
was noted on SDS-PAGE. These results suggest he occurrence of noncovalent complex formation between cholesterol and =,-PI in vitro. 
a,-Proteinase inhibitor; Cholesterol; Complex formation 
1. I~RODUCTION 
Human plasma a,-proteinase inhibitor (q-PI), a 
member of the serpin superfamily, is an acute-phase 
protein synthesized in increased amounts by hepato- 
cytes during inflammation [l]. Functionally q-PI acts 
as a barrier to prevent the breakdown of vulnerable 
elastic tissue, principally in the lung, by the enzymes 
released from inflammatory cells [2]. q-PI diffuses into 
most tissues and is found in most body fluids. Increased 
fecal concentrations of q-PI are found in association 
with infla~atory lesions of the bowel [3]_ 
Hydrophobic peptides from q-PI have recently been 
isolated from human bile 181. Taken together, these find- 
ings indicate that q-PI may possibly interact with 
cholesterol. Such an in vitro interaction is described in 
this report. 
2. MATERIALS AND METHODS 
al-PI-like albumin and qmacroglobulin have been 
found in human aortic intima [4]. Pinocytic uptake of 
the a,-PI-elastase complex was observed on the surface 
of endothelial cells and in smooth-muscle cells border- 
ing the elastic lamina of arterioles [5]. Local sites of 
synthesis such as human blood monocytes and bron- 
choalveolar macrophages also make important contri- 
butions to the q-PI pool in these tissues and body fluids 
za 
Findings in other studies have suggested q-PI to 
have functional additional properties apart from the 
inhibition of serine proteases. The carboxy-ter~nal 
fragment of q-PI, which can be generated during for- 
mation of complexes with serine proteases or during 
proteolytic inactivation, may also be involved in the 
regulation of q-PI synthesis [7]. Corticosteroid binding 
globulin (CBG) is structurally related to the serpins and 
is able to bind a hydrophobic compound, cortisol [17]. 
Electrophoretically pure a,-PI was isolated from human plasma in 
our laboratory, using the method Pannell and coworkers 191. We also 
used two commercially available cz,-PI preparations, Prolastin from 
Bayer and a,-AT from Sigma. Human transferrin was obtained from 
Sigma, neuraminidase (Sialidase) and a standard aqueous olution of 
cholesterol (2 mglml) from Boehringer Mannheim, GmbH, Germany. 
Net - 030 [7-3H(N)]cholesterol spe.c.act. 21.8 Ci/mmol, was obtained 
from New Research Products, Boston, MA, lyophilized bovine trypsin 
(266 U/mg) from Worthington Biochemical corporation, Freehold, 
NJ, and porcine pancreatic elastase Type III from Sigma , St Louis, 
MO. The chromogenic substrate for trypsin [N-a-benzoyl-DL-argin- 
ine-p-nitroanilide hydrochloride (BAPNA)] was obtained from BDH 
Chemicals, England, and that for elastase [N-succinyl-Ala-Ala-Ala-p- 
nitroanilide (SAPNA)] from Sigma. Monospecific rabbit antiserum 
against human a,-PI was purchased from DAKO, Denmark, and 
agarose, Sephadex G-75 superfine and the gel filtration calibration kit 
from Pharmacia, Uppsala, Sweden. All other chemicals were of rea- 
gent grade. 
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In the experiments we used stock solutions of @,-PI and cholesterol 
in 0.015 M Tris buffer, pH 7.4, containing 0.15 M NaCl. Pure n,-PI 
1.78 mg/ml (3.42 x lo-’ M) was mixed with an aqueous solution of 
cholesterol (2 mg/ml (5.17 x 1 Om3 M)) at increasing molar ratios (I : 1, 
1:2, 15, 1:10, 1:20, 1:40, 1:60) and incubated for 24 h at 37°C. In the 
isotopic experiments with [73H(N)]- cholesterol, labelled and unla- 
belled cholesterol were mixed at a ratio 1:lO by weight, immediately 
added to a,-PI samples and incubated for 24 h at 37°C. Gel filtration 
of the mixtures of &,-PI and cholesterol at a molar ratio of I:2 was 
performed on a sephadex G-75 superfine column (0.9 x 60 cm) at 
room temperature. The column was equilibrated with the Tris buffer 
and run at a flow rate of 4 mlih. 1 ml fractions were collected and 
analyzed s~rophotomet~~~ly (A,) and for radioactivity using the 
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Packard TRI-Carb 300C liquid screen infiltration system. Electropho- 
resis in 1% agarose at pH 8.6 and crossed immunoelectrophoresis were 
performed using standard methods [11,12]. SDS-PAGE was carried 
out as previously described with 20 x 30 cm slab gels containing a 
l&15% polyacrylamide gradient with a 2 cm spacing gel [14]. Deter- 
mination of trypsin inhibitory activity was performed with the method 
of Dietz and coworkers [13]. and elastase inhibitory activity as de- 
scribed by Gailbard and coworkers [15]. Desialylation of a,-PI was 
performed as previously described [16]. 
was decreased, and the configuration of the precipitate 
changed and tended to become double peaked. Identical 
results were obtained both in experiments using differ- 
ent antisera to human al-PI and in experiments with 
other al-PI preparations (results not shown). When 
transferrin was used instead of al-PI, no mobility or 
configurational changes were noted. The interaction 
was unaffected by desialylation 
3. RESULTS AND DISCUSSION 3.2. Proteinase inhibitory activity of a,-Pllcholesterol 
mixtures 
3.1. Electrophoresis 
Samples of al-PI/cholesterol mixtures at increasing 
molar ratios (l:l, 1:2, 1:5, 1:lO and 1:20) were studied 
by 1% agarose electrophoresis at pH 8.6. As shown in 
Fig. 1, the al-PI/cholesterol mixture manifested some- 
what retarded mobility towards the anode as compared 
to free al-PI. In addition, the bands were broader and 
less well demarcated than native al-PI. When identical 
samples were analyzed with SDS-PAGE using a lo- 
15% gradient (results not shown), no unequivocal dif- 
ferences between the al-PI/cholesterol mixture and na- 
tive a,-PI could be seen. 
The elastase and trypsin inhibitory capacities of a,- 
PI/cholesterol mixtures are shown in Fig. 3. Cholesterol 
inhibits al-PI activity. With increasing amounts of 
cholesterol, al-PI completely lost antielastase activity, 
but as can be seen in Fig. 3 even at a molar ratio of 1:60 
(cholesterol/a,-PI), 30% trypsin inhibitory activity re- 
mained. 
3.3. Geljltration 
The patterns of a,-PI/cholesterol mixtures were also 
analyzed with crossed immunoelectrophoresis using 
monospecific antisera against human a,-PI (Fig. 2). The 
addition of increasing amounts of cholesterol to al-PI 
produced three different effects: there was some loss of 
immunereactivity already at a molar ratio of 1: 1, the 
mobility of the immune precipate towards the anode 
Native a,-PI at a concentration of 1.78 mg/ml 
(3.8 x 10m5 M) and mixed with cholesterol (2 mg/ml 
(5.1 x 10m3 M)) at molar ratio of 1: 1 or 1:2, was analyzed 
with chromatography on a Sephadex G-75 column. As 
can be seen in Fig. 4, pure a,-PI and a,-PI in mixture 
with cholesterol elute from the column in different frac- 
tions. The molecular weight of a,-PI after mixing with 
cholesterol was calculated to be about 67 kDa. The 
experiments were repeated under identical conditions, 
but with tritiated cholesterol. Radioactivity could only 
Fig. 1. 1% agarose gel electrophoresis of native a,-PI and a,-PI/cholesterol mixtures at pH 8.6. Lanes 1 and 9, normal human plasma; lanes 2 and 
8. native a,-PI; lanes 3, 4, 5, 6 and 7, a,-PI/cholesterol mixtures: 1 M to 1. 2, 5. 10 and 20 M, respectively. Anode at the top. 
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Fig. 2. Crossed immun~~ectrophor~is of native @,-PI and a,-PI/ 
cholesterol mixtures. Normal plasma: A, native @,-PI; and B, C, D, 
E, F and C, mixtures of pure q-PI with increasing amounts of cholest- 
erol (1 M q-PI to 1,2,5,10 and 20 M choIestero1, respectzvely. Anode 
to the left. 
be found in the fractions containing a,-PI/cholesterol 
(Fig. 4). It should be noted that identical results were 
obtained with two other q-PI preparations in mixtures 
with cholesterol. In control experiments where q-PI 
was replaced with transferrin, no differences in elution 
pattern could be seen between native transferrin and 
that mixed with cholesterol. 
It is evident from the electrophoretic data presented 
in Figs. 1 and 2 that an interaction between cholesterol 
and q-PI takes place at 37°C which results in altered 
p~ysicochemical properties of @,-PI; a loss of net charge 
and an abnormal precipitation pattern. This interaction 
also results in diminished antiproteinase activity, most 
pronounced for elastase and less pronounced for trypsin 
(Fig. 3). The inhibitory specificity of serpins is to a 
predominant extent determined by the reactive center. 
Whether cholesterol affects the conformation of the 
molecule so that the reactive center becomes less acces- 
sible to proteases or binds directly to the reactive center 
is presently unknown. The different effects on elastase 
and trypsin also remain unexplained. However, the re- 
sults suggest he occurrence of complex fo~ation be- 
tween cholesterol and q-PI, as clearly shown by the 
findings in gel filtration experiments (Fig. 4). The ap- 
pearance of a relatively high molecular weight (67 kDa) 
complex may be compatible with dimerization, and 
does not simply reflect an addition of 2 mol cholesterol 
to one mol q-PI. 
Moreover, the complex formation is specific. No 
complex formation takes place with transferrin, another 
(but non-serpin) transport glycoprotein. A covalent 
binding to sialic acid residues of q-PI is excluded by the 
results of expe~ments with the desialylated protein and 
with SDS-PAGE. The interaction is probably explained 
by hydrophobic bonds. The binding site(s) is (are) pres- 
ently unknown, but a hydrophobic peptide of q-PI has 
recently been isolated both from human bile, plasma 
and spleen [g]. This peptide may well be responsible for 
cholesterol binding. Its proximity to the reactive center 
of (x,-PI is of particular interest with respect o the loss 
of biological activity of q-PI in complex. The complex 
between cholesterol and q-PI may play an important 
in vivo role in cholesterol transportation, for instance 
in bile. 
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Fig. 3. Percentage inhibition of (A) trypsin and (B) elastase by a,-PI/cholesterol mixtures with increasing amounts of cholesterol. Figures on the 
-x-axis indicate the molar ratios between cholesterol and q-PI. 
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Fig. 4. Gel filtration of native al-PI and q-PI/cholesterol mixture (1 M:2 M) on Sephadex G-75 superfine. Native a,-PI (6-6); q-PI/cholesterol 
(1 M:2 M) mixture (A-A); a,-PI-labelled [73H(N)]cholesterol (1 M:2 M) mixture (O-O); labelled [7’H(N)]cholesterol (x-x). 
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